Exploiting the Metabolism of the Gut Microbiome as a Vehicle for Targeted Drug Delivery to the Colon

Exploiting the Metabolism of the Gut Microbiome as a Vehicle for Targeted Drug Delivery to the Colon

The prevalence of colon-associated diseases has increased significantly over the past several decades, as evidenced by accumulated literature on conditions such as Crohn’s disease, irritable bowel syndrome, colorectal cancer, and ulcerative colitis. Developing therapeutics for these diseases is chal...

Full description

Bibliographic Details
Main Authors: Hamid A. Bakshi, Gerry A. Quinn, Alaa A. A. Aljabali, Faruck L. Hakkim, Rabia Farzand, Mohamed M. Nasef, Naji Abuglela, Prawej Ansari, Vijay Mishra, Ángel Serrano-Aroca, Murtaza M. Tambuwala
Format: Article
Language:English
Published: MDPI AG 2021-11-01
Series:Pharmaceuticals
Subjects:
colon
gut microflora
oral drug delivery
gastrointestinal technology
genetically modified bacteria
probiotics
Online Access:https://www.mdpi.com/1424-8247/14/12/1211

Internet

https://www.mdpi.com/1424-8247/14/12/1211

Similar Items